'Pharmacy Friends'

"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.
Other ways to listen:

Prescription for change: The IRA’s impact on pharmacy

It’s been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments.​ And today, we’re here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience.
 
Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You’ll get a glimpse into Prime’s Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect.

More episodes

'Beyond the business – Stories of corporate kindness'

GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which our experts aim to address.

'Many voices, one purpose - Our 2023 Corporate Social Responsibility Report'

In this episode, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts.

'Beyond the business – Stories of corporate kindness'

Jazz-laden melodies are typically the sonic output of “The Big Easy,” but this week, it’s a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans.
Login Portals
Compliance / Legal
Careers
© 2024 Prime Therapeutics LLC